Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 230

Related Citations for PubMed (Select 22042189)

1.

Atypical presentations of neuromyelitis optica.

Sato D, Fujihara K.

Arq Neuropsiquiatr. 2011 Oct;69(5):824-8. Review. Erratum in: Arq Neuropsiquiatr. 2012 Jan;70(1): doi.org/10.1590/S0004-282X2012000100023.

2.

Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.

Chan KH, Ramsden DB, Yu YL, Kwok KH, Chu AC, Ho PW, Kwan JS, Lee R, Lim E, Kung MH, Ho SL.

Eur J Neurol. 2009 Mar;16(3):310-6. doi: 10.1111/j.1468-1331.2008.02376.x.

PMID:
19138340
3.

Neuromyelitis Optica-AQP4: an update.

Benavente E, Paira S.

Curr Rheumatol Rep. 2011 Dec;13(6):496-505. doi: 10.1007/s11926-011-0211-9. Review.

PMID:
21922173
4.

Neuromyelitis optica: an overview.

Nandhagopal R, Al-Asmi A, Gujjar AR.

Postgrad Med J. 2010 Mar;86(1013):153-9. doi: 10.1136/pgmj.2009.091389. Review.

PMID:
20237009
5.

Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.

Sato DK, Nakashima I, Takahashi T, Misu T, Waters P, Kuroda H, Nishiyama S, Suzuki C, Takai Y, Fujihara K, Itoyama Y, Aoki M.

Neurology. 2013 Jun 11;80(24):2210-6. doi: 10.1212/WNL.0b013e318296ea08. Epub 2013 May 15.

PMID:
23677744
6.

The expanded spectrum of neuromyelitis optica: evidences for a new definition.

Lana-Peixoto MA, Callegaro D.

Arq Neuropsiquiatr. 2012 Oct;70(10):807-13. Review.

7.

Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.

Magaña SM, Pittock SJ, Lennon VA, Keegan BM, Weinshenker BG, Lucchinetti CF.

Arch Neurol. 2009 Aug;66(8):964-6. doi: 10.1001/archneurol.2009.152.

8.

Revised diagnostic criteria for neuromyelitis optica.

Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG.

Neurology. 2006 May 23;66(10):1485-9.

PMID:
16717206
9.

Differential regulation of IgG-NMO autoantibodies on S100Beta protein and disability in relapsing neuromyelitis optica.

Robinson-Agramonte MA, Gonçalves CA, Portela LV, Saiz-Hinarejos A, Oses JP, Motta LS, Muller AP, Marquez Gonzalez ME, Souza DO.

Neuroimmunomodulation. 2010;17(3):177-9. doi: 10.1159/000258717. Epub 2010 Feb 4. Erratum in: Neuroimmunomodulation. 2010;17(6):378. Portela, Valmor L [corrected to Portela, L. Valmor]; Oses, Pierre J [corrected to Oses, Jean Pierre]; Motta, Souza L [corrected to Motta, Luis Souza]; Gomes de Souza, Onofre D [corrected to Souza, Diogo Onofre].

PMID:
20134196
10.

Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study.

Asgari N, Skejoe HP, Lillevang ST, Steenstrup T, Stenager E, Kyvik KO.

BMC Neurol. 2013 Apr 8;13:33. doi: 10.1186/1471-2377-13-33.

11.

[Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies].

Jordan B, Eger K, Kornhuber ME, Zierz S.

Fortschr Neurol Psychiatr. 2008 Jan;76(1):21-7. doi: 10.1055/s-2007-993032. Review. German.

PMID:
18189220
12.

Devic's neuromyelitis optica: a critical review.

Lana-Peixoto MA.

Arq Neuropsiquiatr. 2008 Mar;66(1):120-38. Review.

13.

[Neuromyelitis optica spectrum disorder: a case report].

Mitsuyama T, Yoneyama T, Suzuki S, Kagawa M, Kawamata T.

No Shinkei Geka. 2012 Apr;40(4):337-42. Japanese.

PMID:
22466233
14.

Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody marker.

Weinshenker BG, Wingerchuk DM.

Curr Top Microbiol Immunol. 2008;318:343-56. Review.

PMID:
18219825
15.

[Devic's neuromyelitis optica: diagnosis after 10 years of bilateral severe relapsing optic neuritis].

Déral-Stéphant V, Roux-Lelièvre C, Vignal R, Stéphant E, Faivre A, Alla P.

J Fr Ophtalmol. 2008 Sep;31(7):705-9. French.

16.

[Neuromyelitis optica in children. Two case reports].

Tosello B, Halbert C, Mancini J, Chabrol B, Boucraut J, Milh M.

Arch Pediatr. 2012 Aug;19(8):827-31. doi: 10.1016/j.arcped.2012.05.019. Epub 2012 Jul 11. French.

PMID:
22789744
17.

Neuromyelitis optica (Devic's syndrome).

Wingerchuk DM, Weinshenker BG.

Handb Clin Neurol. 2014;122:581-99. doi: 10.1016/B978-0-444-52001-2.00025-X. Review.

PMID:
24507536
18.

Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.

Akman-Demir G, Tüzün E, Waters P, Içöz S, Kürtüncü M, Jarius S, Yapıcı Z, Mutlu M, Yeşilot N, Vincent A, Eraksoy M.

J Neurol. 2011 Mar;258(3):464-70. doi: 10.1007/s00415-010-5780-4. Epub 2010 Oct 17.

PMID:
20953960
19.

Aquaporin-4 autoantibody: a neurogenic cause of anorexia and weight loss.

Fung EL, Tsung LL, Dale RC.

Dev Med Child Neurol. 2012 Jan;54(1):45-7. doi: 10.1111/j.1469-8749.2011.04099.x.

PMID:
22171929
20.

Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.

Hamnik SE, Hacein-Bey L, Biller J, Gruener G, Jay W.

Semin Ophthalmol. 2008 May-Jun;23(3):191-200. doi: 10.1080/08820530802049921.

PMID:
18432545
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk